Autumn EhnowExecutive Vice President, Policy and Strategic Market Access
Autumn has 25 years of experience in leading pharmaceutical development teams and managing business partnerships. She has led several partnerships with governmental agencies and private pharmaceutical companies and for the development of new medicines. Her career has consisted of ten years in for-profit pharmaceutical companies and fifteen years in non-profit pharmaceutical companies.
At the Institute for OneWorld Health, Ms. Ehnow was integral in forming and managing the Bill and Melinda Gates Foundation grant and the four-company partnership that brought semi-synthetic Artemisinin to market.
As part of the team that founded Medicines360, Autumn was integral in defining and leading the strategy and program implementation at Medicines360. This work is continuing today with a focus on addressing market access barriers and implementing a public health strategy to secure patient’s access affordable medicines.